-
Je něco špatně v tomto záznamu ?
Analysis of Bacterial Pathogens Causing Complicating HAP in Patients with Secondary Peritonitis
J. Chudáček, P. Špička, M. Kolar, M. Stašek, Š. Kolcún, D. Klos, K. Hricová, P. Mlynarcik, V. Pudová, O. Klementová, R. Horáček
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things, at risk of developing hospital-acquired pneumonia (HAP), which considerably worsens their treatment outcomes. This study aimed to extend the existing knowledge by providing more detailed microbiological characteristics of complicating HAP in patients with secondary peritonitis, including the identification of isolated bacterial pathogens and their potential sources. METHODS: The 2015-2019 retrospective study comprised all patients with an intraoperatively confirmed diagnosis of secondary diffuse peritonitis who were classified in accordance with the quick Sepsis Related Organ Failure Assessment scoring system. RESULTS: HAP developed in 15% of patients. The 90-day mortality rates were 53% and 24% in patients with and without HAP; respectively. The most frequent pathogens responsible for HAP were Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae complex and Enterococcus faecalis. Multidrug resistance to antibiotics was found in 38% of bacterial pathogens. Clonal spread of these bacterial pathogens among patients was not detected. Rather, the endogenous characteristic of HAP was confirmed. CONCLUSIONS: The initial antibiotic therapy of complicating HAP in patients with secondary peritonitis must be effective mainly against enterobacteria, including strains with the production of ESBL and AmpC beta-lactamases, Pseudomonas aeruginosa and Enterococcus faecalis. The study further highlighted the importance of monitoring the respiratory tract bacterial microflora in patients with secondary peritonitis. The results should be used for initial antibiotic treatment of complicating HAP instances.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23002746
- 003
- CZ-PrNML
- 005
- 20230421100053.0
- 007
- ta
- 008
- 230413s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antibiotics12030527 $2 doi
- 035 __
- $a (PubMed)36978393
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Chudáček, Josef $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000312864044
- 245 10
- $a Analysis of Bacterial Pathogens Causing Complicating HAP in Patients with Secondary Peritonitis / $c J. Chudáček, P. Špička, M. Kolar, M. Stašek, Š. Kolcún, D. Klos, K. Hricová, P. Mlynarcik, V. Pudová, O. Klementová, R. Horáček
- 520 9_
- $a BACKGROUND: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things, at risk of developing hospital-acquired pneumonia (HAP), which considerably worsens their treatment outcomes. This study aimed to extend the existing knowledge by providing more detailed microbiological characteristics of complicating HAP in patients with secondary peritonitis, including the identification of isolated bacterial pathogens and their potential sources. METHODS: The 2015-2019 retrospective study comprised all patients with an intraoperatively confirmed diagnosis of secondary diffuse peritonitis who were classified in accordance with the quick Sepsis Related Organ Failure Assessment scoring system. RESULTS: HAP developed in 15% of patients. The 90-day mortality rates were 53% and 24% in patients with and without HAP; respectively. The most frequent pathogens responsible for HAP were Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae complex and Enterococcus faecalis. Multidrug resistance to antibiotics was found in 38% of bacterial pathogens. Clonal spread of these bacterial pathogens among patients was not detected. Rather, the endogenous characteristic of HAP was confirmed. CONCLUSIONS: The initial antibiotic therapy of complicating HAP in patients with secondary peritonitis must be effective mainly against enterobacteria, including strains with the production of ESBL and AmpC beta-lactamases, Pseudomonas aeruginosa and Enterococcus faecalis. The study further highlighted the importance of monitoring the respiratory tract bacterial microflora in patients with secondary peritonitis. The results should be used for initial antibiotic treatment of complicating HAP instances.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Špička, Petr $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000331662624 $7 xx0233421
- 700 1_
- $a Kolar, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000346218868 $7 jn20010310083
- 700 1_
- $a Stašek, Martin $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
- 700 1_
- $a Kolcún, Štefan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
- 700 1_
- $a Klos, Dušan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000230974418
- 700 1_
- $a Hricová, Kristýna $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
- 700 1_
- $a Mlynarcik, Patrik $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
- 700 1_
- $a Pudová, Vendula $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
- 700 1_
- $a Klementová, Olga $u Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic
- 700 1_
- $a Horáček, Rostislav $u Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic
- 773 0_
- $w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 12, č. 3 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36978393 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20230421100045 $b ABA008
- 999 __
- $a ok $b bmc $g 1922652 $s 1188953
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 12 $c 3 $e 20230306 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
- LZP __
- $a Pubmed-20230413